| Detected | Trial | Change |
|---|---|---|
| 2026-07-19 | NCT06565689 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy… |
date change Primary completion pushed: 2026-06-30 -> 2028-12 |
| 2026-07-19 | NCT06565689 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy… |
date change Completion pushed: 2026-12-31 -> 2028-12 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07695740 | Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Multiple Myeloma (RRMM) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07010835 | Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT06580301 | Study of YK012 in B-cell Acute Lymphoblastic Leukemia | B-cell Acute Lymphoblastic Leukemia | Recruiting |
| Phase 1 | |||
| NCT06982729 | Study of YK012 in Primary Membranous Nephropathy | Primary Membranous Nephropathy | Recruiting |
| NCT06574568 | A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Multiple Myeloma | Recruiting |
| NCT06565689 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy… | Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma | Recruiting |
| NCT07234474 | A Phase I Study of YK012 in Primary Membranous Nephropathy | Primary Membranous Nephropathy | Not Yet Recruiting |